The State Statistics Service of Ukraine published data on industrial production for 6 months of 2019. Over this period, the country’s overall industrial production index grew by only 0.5% (compared with the first half of last year), but the pharmaceutical industry was notable for its positive dynamics. The production index of pharmaceutical products and preparations amounted to 10.7% increase, while exports increased by 30.5% in the first 5 months of the year.
State Statistic’s Service data is also confirmed by other surveys – according to the pharmaceutical market research conducted by SMD, the market grew by 11% in the first quarter of 2019, and 5 companies are the leaders in the retail segment – Farmak (with a share of 5.7%), Arterium (3.8%), Sanofi (3.5%), Darnitsa (3.3%) and Novartis Group (2.9%).
According to the PharmXplorer / Pharmstandard study of Proxima Research for the first half of 2019, in money terms, sales of all pharmacy products increased by 16.6% compared to the same period last year – up to UAH 48.9 billion. For the eighth consecutive year, the leader is Farmak, which increased sales in money terms by 18% and has a market share of 5.42%, followed by Arterium Corporation with sales growth of 11.7% and a market share of 3.44%. The third position is occupied by Darnitsa, which increased sales by 13.7% and has market share of 3.19%.